Chapter 8.2 quiz update Flashcards
Which of the following contributes to the activation of naive T cells?
a. neutrophils
b. B cells
c. macrophages
d. dendritic cells
e. basophils
d. dendritic cells
Macrophages exhibit all of the following characteristics except _____.
a. they trap and degrade pathogens in secondary lymphoid organs
b. they deliver co-stimulatory signals to naive T cells needed for T-cell priming
c. they migrate from sites of infection to nearby secondary lymphoid organs
d. they remove and degrade apoptotic lymphocytes from secondary lymphoid tissues
e. they donÕt migrate from sites of infection to nearby secondary lymphoid organs
c. they migrate from sites of infection to nearby secondary lymphoid organs
Which of the following describes an activated dendritic cell upon arriving in a lymph node?
a. located in follicles and medulla of the lymph node
b. associated mainly with antigen uptake and processing
c. bears highly elaborated finger-like processes called dendrites
d. expresses low levels of MHC class II molecules
e. carries out apoptosis of lymphocytes
c. bears highly elaborated finger-like processes called dendrites
Activated T cells express _____, which binds to B7 with 20 times higher affinity than CD28 and results in _____ of T-cell activity and proliferation.
a. high-affinity IL-2 receptor; stimulation
b. CD40L; suppression
c. VLA-4; stimulation
d. CTLA4; suppression
d. CTLA4; suppression
Which of the following is associated with immature dendritic cells in the skin before their activation?
a. Toll-like receptors
b. CTLA4
c. CCR7
d. DC-SIGN
e. ICAM-3
a. Toll-like receptors
All of the following are correctly matched except _____.
a. T1: T-bet b. Treg: FoxP3 c. IL-12: dendritic cells d. TH17: RORgammaT e. TH2: Bcl6
e. TH2: Bcl6
. Naive lymphocytes homing to lymphoid tissue use _____ to bind to CD34 and GlyCAM-1 on high endothelial venules (HEV).
a. L-selectin b. CD2 (LFA-2) c. ICAM-1 d. CCL21 e. CD28
a. L-selectin
The co-stimulatory molecule _____ on professional antigen-presenting cells binds _____ on the surface of naive T cells.
a. DC-SIGN; ICAM-3
b. B7; CD28
c. ICAM-1; LFA-1
d. MHC class II; T-cell receptor
e. MHC class II; CD4
b. B7; CD28
An adhesion molecule called _____ is expressed exclusively on activated dendritic cells and binds to _____ on naive T cells in the T-cell areas of secondary lymphoid tissue.
a. DC-SIGN; ICAM-3
b. CD2; LFA-3
c. MHC class II; T-cell receptor
d. L-selectin; GlyCAM-1
e. ICAM-1; LFA-1
a. DC-SIGN; ICAM-3
The area of contact between membranes of a T cell and an antigen-presenting cell where a clustering of proteinÐprotein interactions occur is called a(n)___________.
a. immunoreceptor tyrosine-based activation motif (ITAM)
b. polarization
c. cross-presentation center
d. granuloma
e. immunological synapse
e. immunological synapse
All of the following are included in the central supramolecular activation complex (c-SMAC) except _____.
a. CD4 or CD8 b. ICAM-1 c. CD28 d. T-cell receptor e. PKC-theta
b. ICAM-1
Talin is best described as a _____.
a. protein tyrosine kinase
b. transcriptional activator
c. cytoskeletal protein
d. pro-inflammatory cytokine
e. cytokine receptor that associates with Janus kinases (JAKs)
c. cytoskeletal protein
The primary effect of inositol trisphosphate (IP3) during T-cell activation is to _____.
a. cause an increase in cytosolic calcium concentration
b. activate phospholipase C-gamma
c. activate a MAP kinase cascade
d. facilitate the differentiation of immature effector T cells
e. align the microtubule-organizing center toward the antigen-presenting cell
a. cause an increase in cytosolic calcium concentration
Which of the following is not a transcription factor, a component of a transcription factor, or an activator of transcription?
a. Fos b. AP-1 c. NFkappaB d. NFAT e. Janus kinases (JAKs)
e. Janus kinases (JAKs)
The enzyme that generates diacylglycerol (DAG) and inositol trisphosphate (IP3) from phosphatidylinositol bisphosphate (PIP2) is _____.
a. protein kinase C-theta (PKC-theta)
b. calcineurin
c. phospholipase C-gamma (PLC-gamma)
d. protein tyrosine kinase ZAP-70
e. protein tyrosine kinase Lck
c. phospholipase C-gamma (PLC-gamma)
All of the following statements regarding interleukin-2 (IL-2) or its receptor are true except _____.
a. The low-affinity IL-2 receptor is a membrane-bound heterodimer composed of alpha and beta chains.
b. IL-2 production increases approximately 100-fold if a co-stimulatory signal is delivered.
c. T-cell proliferation occurs upon binding of IL-2 to the high-affinity IL-2 receptor.
d. The high-affinity IL-2 receptor is assembled after T-cell activation.
e. Rapamycin is an immunosuppressive drug that inhibits signaling of IL-2 through the IL-2 receptor.
a. The low-affinity IL-2 receptor is a membrane-bound heterodimer composed of alpha and beta chains.
If a non-professional antigen-presenting cell that lacks co-stimulatory molecules presents peptide:MHC complexes to a T cell specific for that peptide, then _____.
a. the T cell delivers a signal to the non-professional antigen-presenting cell to activate the expression of co-stimulatory molecules.
b. the T cell begins to express the ? chain of the IL-2 receptor.
c. the T cell differentiates into a TH1 cell.
d. T-cell tolerance occurs as a result of anergy.
e. the T cell is more heavily reliant on signals transmitted through CD4 or CD8 in order to become activated.
a. the T cell delivers a signal to the non-professional antigen-presenting cell to activate the expression of co-stimulatory molecules.
Which of the following statements regarding leprosy is false?
a. It is caused by the bacterium Mycobacterium leprae.
b. Disease progression is influenced depending on whether the immune response is polarized toward either a TH1 or TH2 response.
c. The tuberculoid form of leprosy is associated with localized inflammation and granuloma formation.
d. In lepromatous leprosy, the patient makes a TH2 response that clears the mycobacteria from the body.
e. The less severe form of leprosy presents with high levels of IL-2 and IFN-? produced by responding T cells.
d. In lepromatous leprosy, the patient makes a TH2 response that clears the mycobacteria from the body.